Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esthesioneuroblastoma.

D Elkon, S I Hightower, M L Lim

    Cancer
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Esthesioneuroblastoma, a rare nasal tumor, shows bimodal age peaks and better survival in early stages (A and B). Single treatments are effective for early stages, but local recurrence remains a challenge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Swimmer's Ear.

    The Physician and sportsmedicine·2016
    Same author

    Influenza A(H1N1)pdm09 infection in pregnant and non-pregnant women hospitalized in Singapore, May - December 2009.

    Public health·2015
    Same author

    Eye-sparing protocol in sinonasal cancers -vision at what cost?: Preservation of the eye in the treatment of sinonasal malignant neoplasms with orbital involvement.

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2012
    Same author

    NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.

    Journal of animal science·2011
    Same author

    A novel, efficient method to derive bovine and mouse embryonic stem cells with in vivo differentiation potential by treatment with 5-azacytidine.

    Theriogenology·2011
    Same author

    Influenza A/H1N1 (2009) infection in pregnancy--an Asian perspective.

    BJOG : an international journal of obstetrics and gynaecology·2010
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Otorhinolaryngology
    • Neural Crest Tumors

    Background:

    • Esthesioneuroblastoma is an uncommon neural crest tumor originating in the nasal cavity.
    • Ninety-seven cases reported in the literature since 1966 provide a basis for analysis.

    Purpose of the Study:

    • To analyze age and sex distribution, staging, treatment outcomes, recurrence intervals, and survival rates for esthesioneuroblastoma.
    • To evaluate the efficacy of different treatment modalities based on disease stage.

    Main Methods:

    • Analysis of 97 reported cases of esthesioneuroblastoma.
    • Disease staging according to the Kadish et al. system.
    • Evaluation of treatment results including radiotherapy, surgery, and combined approaches.

    Related Experiment Videos

    Main Results:

    • Bimodal age distribution observed with peaks in 11-20 and 51-60 year age groups.
    • Favorable prognosis for early stages (A and B) with 3-year crude survivals of 88.9% and 83.3%.
    • Poor prognosis for Stage C (52.9% 3-year survival); single modality treatment is effective for early stages; local recurrence is the primary failure site (68%).

    Conclusions:

    • Early-stage esthesioneuroblastoma has a favorable prognosis, with single treatment modalities being as effective as combined approaches.
    • Treatment strategies should address the high rate of local recurrence.
    • Overall crude survival was 95.4%, with determinate survival at 70.8%.